Pantoprazol in clinical praxis
Milan Lukáš Orcid.org 1
+ Affiliation
To read this article in full, please register for free on this website.
Benefits for subscribers
Benefits for logged users
Literature
1. Lukáš M, Bultas J. Léčiva určená k léčbě chorob trávicího ústrojí. In: Bultas J, Švihovec J (eds). Farmakologie. [In press]. Praha: Grada Publishing 2018: 523–557.
2. Gyawali CP, Azagury DE, Chan WW et al. Nonerosive reflux disease: clinical concepts. Ann N Y Acad Sci 2018. doi: 10.1111/nyas.13845.
3. Korthouwer R, Lebar N, Barbič-Žagar B. Clinical studies with Krka’s proton pump inhibitors in the treatment of gastroesophageal refux disease reviewed. Krka Med Farm 2014; 26 (38): 92–102.
4. Malfertheiner P, Kandulski A, Venerito M. Proton-pump inhibitors: understanding the complications and risks. Nat Rev Gastroenterol Hepatol 2017; 14 (12): 697–710. doi: 10.1038/nrgastro.2017.117.
5. Dabrowski A, Štabuc B, Lazebnik L. Meta-analysis of the efficacy and safety of pantoprazole in the treatment and symptom relief of patients with gastroesophageal reflux disease – PAN-STAR. Gastroenterology Rev 2018; 13 (1): 6–15.